Abingdon Health PLC

LSE:ABDX (UK)  
£ 0.10 (0%) May 1
At Loss
P/B:
6.67
Market Cap:
£ 12.17M ($ 15.26M)
Enterprise V:
£ 11.18M ($ 14.02M)
Volume:
63.19K
Avg Vol (2M):
386.50K
Also Trade In:
Volume:
63.19K
At Loss
Avg Vol (2M):
386.50K

Business Description

Description
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 1.98
Equity-to-Asset 0.38
Debt-to-Equity 0.56
Debt-to-EBITDA -0.61
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.66
Distress
Grey
Safe
Beneish M-Score -6.29
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -38.2
3-Year FCF Growth Rate -26.3
3-Year Book Growth Rate -4.8

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 23.6
9-Day RSI 43.99
14-Day RSI 51.15
6-1 Month Momentum % -6.09
12-1 Month Momentum % 15.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.79
Quick Ratio 1.59
Cash Ratio 0.95
Days Inventory 49.28
Days Sales Outstanding 52.68
Days Payable 271.36

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.2
Shareholder Yield % 1.42

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 57.35
Operating Margin % -47.29
Net Margin % -41.82
FCF Margin % -44.39
ROE % -75.84
ROA % -37.32
ROIC % -144.05
ROC (Joel Greenblatt) % -187.09
ROCE % -59.14

Financials (Next Earnings Date:2024-10-17 Est.)

LSE:ABDX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Abingdon Health PLC Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £) 5.344
EPS (TTM) (£) -0.007
Beta -1.36
Volatility % 58.12
14-Day RSI 51.15
14-Day ATR (£) 0.009498
20-Day SMA (£) 0.103575
12-1 Month Momentum % 15.63
52-Week Range (£) 0.065 - 0.185
Shares Outstanding (Mil) 121.72

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Abingdon Health PLC Filings

Filing Date Document Date Form
No Filing Data

Abingdon Health PLC Stock Events

Financials Calendars
Event Date Price(£)
No Event Data

Abingdon Health PLC Frequently Asked Questions

What is Abingdon Health PLC(LSE:ABDX)'s stock price today?
The current price of LSE:ABDX is £0.10. The 52 week high of LSE:ABDX is £0.19 and 52 week low is £0.07.
When is next earnings date of Abingdon Health PLC(LSE:ABDX)?
The next earnings date of Abingdon Health PLC(LSE:ABDX) is 2024-10-17 Est..
Does Abingdon Health PLC(LSE:ABDX) pay dividends? If so, how much?
Abingdon Health PLC(LSE:ABDX) does not pay dividend.

Press Release

Subject Date
No Press Release